W. Henry Boom
J Clin Invest.
2007;
117(8):2092–2094
doi:10.1172/JCI32933
This article Copyright © 2007, The American Society for Clinical Investigation
Abstract
|
Full text
|
PDF
M
HC class I–restricted CD8+ T cells are necessary to mount
an immune response against Mycobacterium tuberculosis.
M. tuberculosis antigens can enter MHC class I
cross-processing pathways through a number of different mechanisms, including
via the uptake of antigen-containing apoptotic vesicles released by infected
cells. A study in this issue of the JCI by Hinchey and
colleagues shows that M. tuberculosis inhibits host cell
apoptosis and thus may interfere with optimal cross-priming and action of
CD8+ T cells (see the related article beginning on page 2279).
M. tuberculosis genetically modified to induce apoptosis is
shown to be more effective in priming CD8+ T cells in vivo and
therefore may be a more effective vaccine against tuberculosis than the
currently utilized M. bovis BCG vaccine.
This file is in Adobe Acrobat (PDF) format.
If you have not installed and configured the Adobe Acrobat Reader on your system.
Having trouble reading a PDF?
PDFs are designed to be printed out and read, but if you prefer to read them online, you may find it easier if you increase the view size to 125%.
Having trouble saving a PDF?
Many versions of the free Acrobat Reader do not
allow Save. You must instead save the PDF from the JCI Online page you downloaded it from. PC users:
Right-click on the Download link and choose the option that says something like "Save Link As...".
Mac users should hold the mouse button down on the link to get these same options.
Having trouble printing a PDF?
- Try printing one page at a time or to a newer printer.
- Try saving the file to disk before printing rather than opening it "on the fly." This requires that you
configure your browser to "Save" rather than "Launch Application" for the file type "application/pdf", and can
usually be done in the "Helper Applications" options.
- Make sure you are using the latest version of Adobe's Acrobat Reader.